ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

NCI director apologizes to cancer centers for inaction on working group report.

October 31, 2003

Cancer Letter Editor Wine Reporting Awards

June 11, 1999

Final Panel Meeting For Benno Schmidt; He, Upton Defend Shubik, Eppley

March 17, 1978